Witness· Theranos
Fabrizio Bonanni
Former Amgen executive and Theranos board member who joined the company during its 2016 restructuring.
AppearedFederal Criminal Trial
269 lines·3 appearances·4 mentions
About
Called by the defense, Bonanni described the Minilab and quality, compliance, and regulatory work undertaken after he joined Theranos's board in 2016. Cross-examination established that his knowledge postdated earlier investor representations and that the Minilab he discussed was neither commercially used for patient testing nor FDA cleared.
Trial Record (7)
FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022
Testimony (3)
Direct
Fabrizio Bonanni — Direct
Day 36CrossFabrizio Bonanni — Cross
Day 36RedirectFabrizio Bonanni — Redirect
Day 36